Phase 3 programs underway for DURAVYU in wet AMD and DME, the largest multi-billion-dollar retinal disease markets –– Pivotal Phase 3 trials in ...
Phase 3 programs underway for DURAVYU in wet AMD and DME, the largest multi-billion-dollar retinal disease markets - - Pivotal Phase 3 trials in wet AMD on track for data readout beginning in mid-2026 ...
For the first time, an international research team led by Nanyang Technological University, Singapore (NTU Singapore) has ...
News-Medical.Net on MSN
Research breakthrough could provide a new, non-invasive way to assess retinal health
For the first time, an international research team led by Nanyang Technological University, Singapore (NTU Singapore) has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback